August 21-23, 2018

Boston, MA

Day One
Wednesday, August 22, 2018

Day Two
Thursday, August 23, 2018

07.30
Registration & Networking

08.20
Chairs Opening Remarks

  • Brian Berridge Associate Director, National Toxicology Program, Scientific Director , NIEHS

08.30
IQ Consortium Microphysiological Systems Working Group: History & Updates

Synopsis

– Describing the consortium and key past contributions
– Reviewing current changes and insights into ongoing activities of the consortium
– Highlighting future direction & objectives

Adding Human Relevancy into the Pipeline – 3D Systems Informing Disease Biology

09.00
PREDICT-96: A Microfluidic High-throughput Microphysiological System Platform

09.30
Pluripotent Stem Cell Models of Lung Disease in 3D

10.00
MicroHeart: A Screening-Ready, Physiologically Relevant Human iPSC-Derived Cardiomyocte Platform

10.30
Speed Networking

11.00
Morning Refreshments

Accelerating Target & Phenotypic Based Discovery

11.30 Creating Physiological Disease Models for Drug Discovery

Brian Wamhoff, Co-founder and Head of Innovation, HemoShear Therapeutics

Enhancing the Predictive Confidence of Preclinical Safety Assessments

11.30 Application of 3D Hepatic Cultures for Risk Assessment of Drug Induced Liver Injury

Dominic Williams, Associate Director – Preclinical Hepatic Safety, AstraZeneca